Volume 27, Number 8—August 2021
Dispatch
Replication in Human Intestinal Enteroids of Infectious Norovirus from Vomit Samples
Table
Sample name | Genotype† | Titer, GEq/mL‡ |
---|---|---|
V1 | GII.4§ | 7.86 × 109 |
V2 | GII.4 | 1.36 × 109 |
V3 | GII.4 | 5.28 × 108 |
V5 | GII.4 | 1.44 × 108 |
V6 | GII.2 | 8.55 × 107 |
V8 | GII.4 | 1.16 × 108 |
V11 | GII.17 | 1.21 × 108 |
V12 | GII.4 | 1.25 × 107 |
V18 | GII.2 | 5.41 × 107 |
V19 | GII.4 | 2.00 × 108 |
V20 | GII.2 | 8.73 × 108 |
V21 | GII.4 | 5.92 × 107 |
V22 | GII.4 | 1.91 × 107 |
V23 | GII.4 | 2.83 × 108 |
V24 | GII.4 | 1.66 × 109 |
V25 | GII.4 | 1.61 × 1010 |
V29 | GII.4 | 1.51 × 108 |
V30 | GII.4 | 8.91 × 106 |
V32 | GII.4 | 9.55 × 107 |
V33 | GII.4 | 3.52 × 108 |
*Bold indicates vomit samples that showed successful norovirus replication. GEq, genomic equivalent. †Norovirus genotype determined by partial sequencing of the VP1 gene encoding the major capsid protein. ‡Norovirus titer (GEq/mL) in undiluted vomit used to infect human intestinal enteroids. 100µL of 1:100 diluted sample was used as inoculum. §All GII.4 norovirus detected belonged to the GII.4 Sydney 2012 variant.
Page created: July 15, 2021
Page updated: July 18, 2021
Page reviewed: July 18, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.